[1]
|
Joint Task Force of the EFNS and the PNS (2010) European Federation of Neurological Societies/Peripheral Nerve Society Guidelines on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society—First revision. Journal of the Peripheral Nervous System, 15, 185-195. http://dx.doi.org/10.1111/j.1529-8027.2010.00278.x
|
[2]
|
Busby, M. and Donaghy, M. (2003) Chronic dysimmune neuropathy, a subclassification based upon the clinical features of 102 patients. Journal of Neurology, 250, 714-724. http://dx.doi.org/10.1007/s00415-003-1068-2
|
[3]
|
Chassande, B. and Leger, J.M. (1993) Neurological manifestations of monoclonal gammopathies. Revue du Praticien, 43, 314-316.
|
[4]
|
Drappatz, J. and Batchelor, T. (2004) Neurological complications of plasma cell disorders. Clinical Lymphoma, 5, 163-171. http://dx.doi.org/10.3816/CLM.2004.n.022
|
[5]
|
Ponsford, S., Willison, H., Veitch, J., Morris, R. and Thomas, P.K. (2000) Long-term clinical and neurophysiological follow-up of patients with peripheral neuropathy associated with benign monoclonal gammopathy. Muscle Nerve, 23, 164-174. http://dx.doi.org/10.1002/(SICI)1097-4598(200002)23:2<164::AID-MUS4>3.0.CO;2-Y
|
[6]
|
Uldry, P.A., Steck, F. and Regli, F. (1984) Manifestations neurologiques des gammapathies monoclonales. Schweizerische Medizinische Wochenschrift, 114, 1678-1685.
|
[7]
|
Silberman, J. and Lonial, S. (2008) Review of peripheral neuropathy in plasma cell disorders. Hematological Oncology, 26, 55-65. http://dx.doi.org/10.1002/hon.845
|
[8]
|
Merkies, I.S. and Faber, C.G. (2012) Fatigue in immunemediated neuropathies. Neuromuscular Disorders, 22, 203-207.
|
[9]
|
Galiè, E., Maschio, M. and Jandolo, B. (2005) Cerebellar atrophy and monoclonal gammopathy of undetermined significance: A possible correlation? Journal of Experimental & Clinical Cancer Research, 24, 483-485.
|
[10]
|
Rentzos, M., Michalopoulu, M., Gotosidis, K., Caponi, A., Bonakis, A., Kilidireas, K. and Nikolaou, C. (2004) Unusual association of multiple sclerosis with monoclonal gammopathy of undetermined significance (MGUS): Two cases. Functional Neurology, 19, 253-256.
|
[11]
|
Galiè, E., Pietrangeli, A., Maschio, M., Pace, A., Vidiri, A., Carosi, M. and Jandolo, B. (2003) Demyelinating disease in monoclonal gammopathy of undeterminated significance. Journal of Experimental & Clinical Cancer Research, 22, 337-339.
|
[12]
|
Trèfouret, S., Azulay, J.-Ph, Pouget, J., Boucraut, J. and Serratrice, G. (1996) Sclerose en plaques tardive et gammapathie monoclonal sérique: Association fortuite? Revista de Neurología, 152, 554-556.
|
[13]
|
Cai, Z., Blumberg, P.C., Koblar, S.A., Kathy, C., Manavis, J., Ghabriel, M.N. and Thompson, P.D. (2004) Peripheral nervous system and central nervous system pathology in rapidly progressive lower motor neuron syndrome with immunoglobulin M anti GM1 ganglioside antibody. Journal of the Peripheral Nervous System, 9, 79-91. http://dx.doi.org/10.1111/j.1085-9489.2004.009206.x
|
[14]
|
Leger, J.M., Younes-Chennoufi, A..B., Zuber, M., Bounche, P., Jauberteau, M.O., Dormont, D., Danton, F., Baumann, N. and Brunet, P. (1992) Frequency of central lesion in polyneuropathy associated with IgM monoclonal gammopathy: An MRI, neurophysiological and immunochemical study. Journal of Neurology, Neurosurgery & Psychiatry, 55, 112-115. http://dx.doi.org/10.1136/jnnp.55.2.112
|
[15]
|
Barbieri, S., Nobile-Orazio, E., Baldini, L., Fayoumi, Z., Manfredini, KE. and Scarlato, G. (1997) Visual evoked potentials with neuropathy and macroglobulinemia. Annals of Neurology, 22, 663-666. http://dx.doi.org/10.1002/ana.410220520
|
[16]
|
Quarles, R.H. (2007) Myelin-associated glycoprotein (MAG): Past, present and beyond. Journal of Neurochemistry, 100, 1431-1438.
|
[17]
|
Fluri, F., Ferracin, F., Beat, E. and Steck, A.J. (2003) Microheterogeneity of anti-myelin-associated glycoprotein antibodies. Journal of the Neurological Sciences, 207, 43-49. http://dx.doi.org/10.1016/S0022-510X(02)00359-3
|
[18]
|
Di Trapani, G., Carnevale, A., Cioffi, R.P., Massaro, A.R. and Profice, P. (1996) Multiple Sclerosis associated with peripheral demyelinating neuropathy. Clinical Neuropathology, 15, 135-138.
|
[19]
|
Drulovic, D.S., Levic, Z., Stoiasavljevic, N., Trikic, R., Cvetkovic, D. and Apostolski, S. (1998) Unusual association of multiple sclerosis and tomaculous neuropathy. Journal of the Neurological Sciences, 157, 217-222. http://dx.doi.org/10.1016/S0022-510X(98)00054-9
|
[20]
|
Falcone, M., Scalise, A., Minisci, C., Romito, D., Cancelli, I. and Gigli, G.L. (2006) Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polineuropathy. Neurological Sciences, 27, 58-62. http://dx.doi.org/10.1007/s10072-006-0565-3
|
[21]
|
Pirko, I., Kuntz, N.L., Patterson, M., Keegan, B.M., Weinshenker, B.G. and Rodriguez, M. (2003) Contrasting effects of INF beta and IVIG in children with central and peripheral demyelination. Neurology, 60, 1697-1699. http://dx.doi.org/10.1212/01.WNL.0000064163.94122.EB
|
[22]
|
Pogorzelski, R., Baniukiewicz, E. and Drozdowski, W. (2004) Subclinical lesions of peripheral nervous system in multiple sclerosis patients. Neurologia i Neurochirurgia Polska, 38, 257-264.
|
[23]
|
Quan, D., Pelak, V., Tanabe, J., Duraira, V. and Kleinschmidt-Demasters, B.K. (2005) Spinal and cranial hypertrophic neuropathy in multiple sclerosis. Muscle Nerve, 31, 772-779. http://dx.doi.org/10.1002/mus.20312
|
[24]
|
Roy, Y.I., Alexander, C.B. and Oh, S.J. (1983) Multiple sclerosis and hypertrophic demyelinating peripheral neuropathy. Muscle Nerve, 6, 312-316. http://dx.doi.org/10.1002/mus.880060411
|
[25]
|
Tachi, N., Ishikawa, Y., Tsuzuki, A., Minami, R., Sasaki, K. and Shinoda, M. (1985) A case of childhood multiple sclerosis with peripheral neuropathy. Neuropediatrics, 16, 231-234. http://dx.doi.org/10.1055/s-2008-1059543
|
[26]
|
Laura, M., Leong, W., Murray, M.F., Ingle, G., Miszkiel, K.A., Altmann, D.R., Miller, D.H. and Reilly, M.M. (2005) Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cord. Neurology, 64, 914-916. http://dx.doi.org/10.1212/01.WNL.0000152842.11864.D0
|
[27]
|
Nadkarni, N. and Lisak, R.P. (1993) GuillanBarrè syndrome (GBS) with bilateral optic neuritis and central white matter disease. Neurology, 43, 843-842. http://dx.doi.org/10.1212/WNL.43.4.842
|
[28]
|
Pinedda, A.A., Ogata, K., Osoegawa, M., Murai, H., Shigeto, H., Yoshiura, T., Tobimatsu, S. and Kira, J. (2007) A distinct subgroup of chronic inflammatory demyelinating polineuropathy with CNS demyelination and favoreble response to immunotherapy. Journal of the Neurological Sciences, 255, 1-6. http://dx.doi.org/10.1016/j.jns.2007.01.004
|
[29]
|
de Lau, L.M.I. and Breteler, M.M.B. (2006) Epidemiology of Parkinson’s disease. The Lancet Neurology, 5, 525-535. http://dx.doi.org/10.1016/S1474-4422(06)70471-9
|
[30]
|
Mariotti, C., Gellero, C., Rimoldi, M., Mineri, R., Uziel, G., Zorzi, G., Pareyson, D., Piccolo, G., Gambi, D., Piacentini, S., Squitieri, F., Capra, R., Castelletti, B. and Di Donato, S. (2004) Ataxia with isolatedvit. Edeficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurological Sciences, 25, 130-137. http://dx.doi.org/10.1007/s10072-004-0246-z
|
[31]
|
Dispenzieri, A. and Kyle, R.A. (2005) Neurological aspects of multiple myeloma and related disorders. Best Practice & Research Clinical Haematology, 18, 673-688. http://dx.doi.org/10.1016/j.beha.2005.01.024
|
[32]
|
Bida, J.P, Kyle, R.A., Therneau, T.M., et al. (2009) Disease associations with monoclonal gammopathy of undetermined significance: A population-based study of 17.398 patients. Mayo Clinic Proceedings, 84, 685-693. http://dx.doi.org/10.4065/84.8.685
|